Molecular Profiling Project

Inclusion Criteria: * The availability of sufficient archival tumor tissue specimen (15 slides of 4 microns per section) * Age ≥ 21 years * WHO performance status ≤ 2 * Life expectancy of ≥ 12 weeks * Patients should have adequate organ function for potential consideration into clinical trials (routine blood tests are valid within 14 days before enrollment): * Adequate bone marrow function as shown by: ANC ≥ 1.0 x 10\^9/L, Platelets ≥ 75 x 10\^9/L, Hb ≥ 7.5 g/dL * Alanine aminotransferase (ALT) and aspirate aminotransferase (AST) normal range (or ≤3.0 x ULN if liver metastases are present) * Willing to provide signed informed consent * Patients whom do not fulfill the above criteria may be discussed on a case-by-case basis with the study team, for potential enrolment Exclusion Criteria: \- No more than 3 lines of cytotoxic chemotherapy at the time of enrolment